Plunkett Research Online: Harpoon Therapeutics Inc

HARPOON THERAPEUTICS INC (HARP:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company developing a novel class of T cell engagers that utilizes the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient’s own T cells to kill tar.....



Harpoon Therapeutics Inc
Ticker: HARP
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 650 443-7400
Fax:
Address: 131 Oyster Point Blvd
Suite 300
South San Francisco, CA 94080 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Biological Product (except Diagnostic) Manufacturing
Contacts Description

Gerald McMahon CEO/Director/President
Georgia Erbez CFO
See More
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company developing a novel class of T cell engagers that utilizes the body’s immune system to treat patients suffering from cancer and other diseases. T cell engagers are engineered proteins that direct a patient’s own T cells to kill tar.....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Tri-specific T cell Activating Construct (TriTAC)
HPN424
HPN536
HPN271
HPN328
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: